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Project Summary 
Pyriscence is a project that myself and another M4, Alex Blaty, started working on in 
early 2017. In a nutshell, it is a project, now company, that is dedicated to bringing a 
new biotech product to market. The product is a Foley catheter that produces 
antimicrobial free radicals on the inner and outer surface following application of 
energy from a special power supply to embedded wires in the catheter. This project 
started out as Alex and I simply trying to see what we could make happen in our 
backyard with a soldering iron, but soon gained traction, in no small part to the 
University of Michigan Medical School (and the greater University of Michigan) 
supporting us. 
 
Action Items/Outcome 
Critical Thinking/Discovery: We’ve spent a great amount of time going back to the 
basics of physics to refine the design of our catheter, as well as delving into the lab-
based microbiology techniques to create our own in vitro testing protocols for our 
catheter. Every step, along the way, we were doing something with no instruction 
manual, and there was always something that didn’t work that we needed to fix or 
optimize.  
 
Leadership/Teamwork/Communication: Starting right from the start, Alex and I were 
partners and actually had skin in the game, by starting an LLC for legal protection. 
This involved negotiations regarding assignment of percentages. Also, we developed 
over the first few months in particular, to be more independent and trust what the 
other member was doing without needing to check their work. Another great example 
of when teamwork came into play was when we started working with the Law Clinic 
at UM to do a full Intellectual Property review of previously submitted patents, and 
then draft up a rather unwieldy document with facts and figures. It took several 
months, which actually spanned 3 different pairs of law students, so trying to keep 
them on-track and always up to speed was quite important.  
Finish prototype: not finished, went to Cook Medical, saw the production line, spoke 
to VPs, chose to pivot and protect IP more firmly with the limited time and funds we 
had available.  
 
Animal Testing: could not complete, given lack of final prototype with balloon 
occlusion tip.  
 
Mechanism of action: Worked with the chemistry department, found there is a slow 
ellution of reactive oxygen (and other species) from the polymer, even when not 
activated. May explan in vitro testing inconsistencies, needs to be further refined. 
 
In Vitro testing: quite robust, but some needs to be redone, given the potential new 
found mechanism of action. 
 
IP: Preliminary patent submitted, working on finding council that will file the final 
patent. Have one offer to do so for IP. 
 
Business: Won a Venturewell grant, went to conference in Boston, learned more about 
next steps moving forward. 
 
Conclusion/Reflection 
We have now brought it to a point where we have a preliminary patent application 
submitted to the US Patent Office, we have done in vitro testing in an ID laboratory 
demonstrating efficacy, and have been in frequent communication with people 
throughout various schools (Chemistry, Engineering, Physics, Law) throughout the 
university as well as industry outside of the University. Moving forward, we are 
trying to bring this product to a point where it has enough momentum to be picked up 
by a larger biotech company before we start residency. The things we need to do 
before that happens is garner some in vivo data, which we are planning on doing 
through a sheep model of UTI in Dr. Bartlett’s lab. In order to do this, we still need to 
further optimize the catheter’s design, primarily focusing on creating a more stable 
occlusive balloon at the tip, which has been proving difficult. We are in the process of 
applying for the Venturewell grant, which will provide additional funding, but also 
more guidance/structure moving forward. We are also discussing with various 
biomedical engineers the best way to solve our occlusive balloon issue. Overall, this 
has been one of the most educational experiences of my life, and it is because of the 
true interdisciplinary requirements of tackling a project like this. This was a super 
educational experience, and it was certainly worth the time and effort I’ve put into it 
over the last couple of years. The extra time during the M4 year did give extra 
flexibility, that let us push it forward much more than I expected. We’ve run into 
walls, though, and ultimately didn’t get it as far as we had hoped, before residency 
starts. It is in an uncertain place, and likely needs to be handed off to a BME person to 
take on full time. 
